Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|C6-ceramide||PP2A Activator 7||C6-ceramide is an activator of PP2A via binding directly to SET, which may result in tumor suppression (PMID: 24025258, PMID: 32374916).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||prostate cancer||not applicable||C6-ceramide||Preclinical||Actionable||In a preclinical study, C6-ceramide treatment of prostate cancer cells prevented the association between SET and PP2A, which resulted in cell death in culture (PMID: 24025258).||24025258|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|